Lucemyra
NDC Package 27505-050-36

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lucemyra is lofexidine is used to decrease withdrawal symptoms caused by stopping opioids. Marketed by Us Worldmeds, Llc, this product is identified by NDC 27505-050 and is authorized under FDA application NDA209229.

Identification & Billing

NDC Package Code
27505-050-36
Package Description
1 BOTTLE in 1 CARTON / 36 TABLET, FILM COATED in 1 BOTTLE
Product Code
27505-050
11-Digit Billing Format
27505005036
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Lucemyra
Dosage Form
-
Usage Information
Lofexidine is used to decrease withdrawal symptoms caused by stopping opioids. It can be used as part of a complete treatment program for drug abuse (such as compliance monitoring, counseling, behavioral contract, lifestyle changes).

Regulatory & Marketing

Labeler Name
Us Worldmeds, Llc
FDA Application #
NDA209229
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-18-2018
End Marketing Date
03-04-2022
Listing Expiration
03-04-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (27505-050). Click a package code to view its specific billing and regulatory data.

27505-050-03
1 BOTTLE in 1 CARTON / 36 TABLET, FILM COATED in 1 BOTTLE
27505-050-96
1 BOTTLE in 1 CARTON / 96 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 27505-050-36 identifies a specific commercial package of 1 bottle in 1 carton / 36 tablet, film coated in 1 bottle of Lucemyra, labeled by Us Worldmeds, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Us Worldmeds, Llc on June 18, 2018. The current certification is valid through March 04, 2022.

What are the primary indications for this medication?

Lofexidine is used to decrease withdrawal symptoms caused by stopping opioids. It can be used as part of a complete treatment program for drug abuse (such as compliance monitoring, counseling, behavioral contract, lifestyle changes).

How is this Us Worldmeds, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 27505005036. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
27505-050-36
11-Digit CMS (5-4-2)
27505-0050-36

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.